US Military Service May Impact Risk of Certain Cancers
Researchers have found several differences in cancer rates between members of the US military and the general US population.
Researchers have found several differences in cancer rates between members of the US military and the general US population.
Pembrolizumab plus chemoradiotherapy is under priority review for newly diagnosed, high-risk, locally advanced cervical cancer.
Mississippi had the nation’s second-highest age-adjusted cervical cancer mortality rate from 2016 through 2020.
Neoadjuvant chemotherapy followed by surgery is not superior to concomitant chemoradiotherapy for patients with stage IB2-IIB cervical cancer, phase 3 data suggest.
Pharmaceutical experts review ocular adverse effects related to antibody-drug conjugates.
Screening for breast, colorectal, cervical, and lung cancer may have translated to as many as 16.2 million life-years gained in the US.
The family of Henrietta Lacks has filed another in a series of planned lawsuits related to the HeLa cell line.
Henrietta Lacks’s cells were taken without her knowledge while she was a cancer patient more than 70 years ago.
Historically redlined census tracts were significantly less likely to meet targets for breast, colon, and cervical cancer screening.
One additional recommended cervical cancer screening was associated with an increase in the risk of preterm delivery.